| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/31/2012 | US8232257 RNA interference mediated inactivation of hepatitis B virus in a subject |
| 07/31/2012 | US8232256 Means for inhibiting the expression of protein kinase 3 |
| 07/31/2012 | US8232252 Immunoglobulin/bone morphogenic protein fusion for treatment and prevention of inflammatory disorders |
| 07/31/2012 | US8232102 deliverying a therapeutic agent (DNA, CFTR genes, peptide, antibody etc. ) contained in targeting particles (e.g. magnetite) to a cell using an electromagnet to apply a magnetic force so as to tend to move particles towards magnet and at the same time moving the magnet |
| 07/31/2012 | US8232099 Method for transcription/degradation dual control of protein by antibiotic |
| 07/31/2012 | US8232098 p49/STRAP is a novel protein involved in gene regulation and cell proliferation |
| 07/31/2012 | US8232087 Subtilases |
| 07/31/2012 | US8232085 Isoform of bruton's tyrosine kinase (BTK) protein |
| 07/31/2012 | US8232083 Method of producing lycopene using recombinant Escherichia coli |
| 07/31/2012 | US8232081 Methods and microorganisms for production of panto-compounds |
| 07/31/2012 | US8232080 Variant Hyprocrea jecorina CBH1 cellulases |
| 07/31/2012 | US8232078 Methods of using improved polymerases |
| 07/31/2012 | US8232077 Oocytes derived from ovarian culture initially containing no oocytes |
| 07/31/2012 | US8232076 Neurogenin |
| 07/31/2012 | US8232052 Methods of selecting a dopaminergic neuron proliferative progenitor cells using Lrp4/Corin markers |
| 07/31/2012 | US8231917 Antimicrobial peracid compositions with selected catalase enzymes and methods of use in aseptic packaging |
| 07/31/2012 | US8231880 Simian subfamily C adenoviruses SAdV-40, -31, and -34 and uses thereof |
| 07/31/2012 | US8231861 Identifying candidate therapeutic agents for use in the treatment of acute pancreatitis; drug screening; Toll-Like Receptor 4 (TLR4) |
| 07/31/2012 | CA2662837C Methods and substances for isolation and detection of small polynucleotides |
| 07/31/2012 | CA2526831C Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina) |
| 07/31/2012 | CA2488399C Systems and methods for constructing genomic-based phenotypic models |
| 07/31/2012 | CA2475214C Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| 07/31/2012 | CA2473187C Mismatch endonucleases and methods of use |
| 07/31/2012 | CA2471656C Antibody against fibroblast growth factor-23 |
| 07/31/2012 | CA2441903C Single-domain brain-targeting antibody fragments derived from llama antibodies |
| 07/31/2012 | CA2411919C Immunization of dairy cattle with chimeric gapc protein against streptococcus infection |
| 07/31/2012 | CA2404688C Nuclear factor .kappa.b inducing factor |
| 07/31/2012 | CA2372464C Isolating biological modulators from biodiverse gene fragment libraries |
| 07/31/2012 | CA2370948C Growth factor homolog zvegf4 |
| 07/31/2012 | CA2362896C Vascular adhesion molecules and modulation of their function |
| 07/31/2012 | CA2348624C Adenovirus-mediated gene therapy |
| 07/31/2012 | CA2341018C Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 07/31/2012 | CA2323570C Production of biofilaments in transgenic animals |
| 07/31/2012 | CA2272407C Method and compositions for stimulation of an immune response to a differentiation antigen stimulated by an altered differentiation antigen |
| 07/31/2012 | CA2223402C Methods of inhibiting phagocytosis |
| 07/28/2012 | CA2766412A1 Antifungal metabolites from fungal endophytes of pinus strobus |
| 07/26/2012 | WO2012100176A2 Macrocyclic compounds with a hybrid peptidic/non-peptidic backbone and methods for their preparation |
| 07/26/2012 | WO2012100027A2 Epigenetic biomarkers for liver disease |
| 07/26/2012 | WO2012099983A1 Nav1.7 knockout mice and uses thereof |
| 07/26/2012 | WO2012099940A2 Methods and compositions for treating ocular disease |
| 07/26/2012 | WO2012099934A2 Butanol production by microorganisms having nadh coupling |
| 07/26/2012 | WO2012099871A1 Modulation of lrch4 activity and therapeutic application thereof |
| 07/26/2012 | WO2012099832A2 Enzymatic ligation of nucleic acids |
| 07/26/2012 | WO2012099755A1 Pegylated lipids and their use for drug delivery |
| 07/26/2012 | WO2012099540A1 Cmv promoter variants |
| 07/26/2012 | WO2012099528A1 Drought resistant plants and methods for making the same using transcriptional regulators |
| 07/26/2012 | WO2012099448A2 RECOMBINANT ADENOVIRUS EXPRESSING αA-CRYSTALLIN GENE AND GENE THERAPY FOR RETINAL VASCULAR DISEASE USING SAME |
| 07/26/2012 | WO2012099447A2 Transgenic pig expressing stnfr1-fc genes and the use thereof |
| 07/26/2012 | WO2012099396A2 A microorganism having enhanced l-amino acids productivity and process for producing l-amino acids using the same |
| 07/26/2012 | WO2012099295A1 Method for detecting immune gene regulating onset of cancer in ionizing radiation irradiated mice, and immune gene group |
| 07/26/2012 | WO2012099279A1 Nucleic acid construct for expressing oxidative stress indicator and use thereof |
| 07/26/2012 | WO2012099243A1 Gene capable of regulating obesity/insulin sensitivity |
| 07/26/2012 | WO2012099104A1 Method for evaluation of regenerated cartilage |
| 07/26/2012 | WO2012099018A1 Novel esterase derived from foliage compost |
| 07/26/2012 | WO2012098692A1 Composition for inhibiting target gene expression |
| 07/26/2012 | WO2012098662A1 Recombinant yeast and method for producing substance using same |
| 07/26/2012 | WO2012098537A1 Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells |
| 07/26/2012 | WO2012098517A1 Plants having enhanced yield-related traits and method for making the same |
| 07/26/2012 | WO2012098367A1 Delivery of a selectively replicating herpes simplex viral vector to the brain by convection- enhanced delivery (ced) |
| 07/26/2012 | WO2012098246A1 Expression of plant peroxidases in filamentous fungi |
| 07/26/2012 | WO2012098234A1 Biologically active nucleotide molecules for selectively killing off cells, use thereof, and application kit |
| 07/26/2012 | WO2012098119A2 Protein expression in plants |
| 07/26/2012 | WO2012098111A1 Vectors for nucleic acid expression in plants |
| 07/26/2012 | WO2012098100A1 S/mar containing expression vectors, cell and cell lines as well as methods using the same |
| 07/26/2012 | WO2012097720A1 Highly glyphosate-resistant mutated gene, method of modification and use thereof |
| 07/26/2012 | WO2012097668A1 Protease of trichoderma reesei and preparation method and usage thereof |
| 07/26/2012 | WO2012097635A1 NITROGEN ABSORPTION EFFICIENCY AND YIELD IMPROVING RICE GENE OsPTR9 AND USE THEREOF |
| 07/26/2012 | WO2012077898A3 Metabolic diseases-related odorant receptor genes and use thereof |
| 07/26/2012 | WO2012072096A8 Method for cellular rna expression |
| 07/26/2012 | WO2012064960A3 Compositions and methods for generating adeno-associated viral vectors with undetectable capsid gene contamination |
| 07/26/2012 | WO2012060666A3 Method for producing human epidermal growth factor in large volume from yeast |
| 07/26/2012 | WO2012057527A3 Method for mass production of factor vii/viia |
| 07/26/2012 | WO2012053823A3 Fusion protein having factor ix activity |
| 07/26/2012 | WO2012052468A3 Novel fatty acid desaturases, elongases, elongation components and uses therof |
| 07/26/2012 | WO2012050402A3 Cell-permeable recombinant parkin protein and a pharmaceutical composition for treating degenerative brain diseases containing the same |
| 07/26/2012 | WO2012048113A3 Biomarkers of cancer |
| 07/26/2012 | WO2012047325A3 N-end rule protease activity indication methods and uses thereof |
| 07/26/2012 | WO2012045088A9 Combinatorial design of highly efficient heterologous pathways |
| 07/26/2012 | WO2012034039A3 Anti-il-1 beta antibodies and methods of use |
| 07/26/2012 | WO2012030196A9 Oligonucleotide marker and method for identifying the same |
| 07/26/2012 | WO2012011114A3 Sequence specific double-stranded dna/rna binding compounds and uses thereof |
| 07/26/2012 | WO2009038581A8 Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline and oxidative conditions |
| 07/26/2012 | US20120192318 Transformation system for Camelina sativa |
| 07/26/2012 | US20120192317 SELECTING AND STABILIZING dsRNA CONSTRUCTS |
| 07/26/2012 | US20120192316 Polypeptides having lipase activity and polynucleotides encoding same |
| 07/26/2012 | US20120192314 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene |
| 07/26/2012 | US20120192313 Method for Modifying Plant Architecture and Enhancing Plant Biomass And/Or Sucrose Yield |
| 07/26/2012 | US20120192312 Production of Plants with Reduced Lignin Content |
| 07/26/2012 | US20120192311 Ripening promoter |
| 07/26/2012 | US20120192310 Novel Bacillus thuringiensis Gene With Lepidopteran Activity |
| 07/26/2012 | US20120192308 Method for Providing Fertile Plants via Induction of BBM During Transformation |
| 07/26/2012 | US20120192305 Tomato line chi 18-2101 |
| 07/26/2012 | US20120192301 Methods and compositions for gene correction |
| 07/26/2012 | US20120192298 Method for genome editing |
| 07/26/2012 | US20120192297 Screening method utilizing thalidomide-targeting factor |
| 07/26/2012 | US20120192296 Preparation of isolated agonist anti-edar monoclonal antibodies |
| 07/26/2012 | US20120191163 Method and system for manipulating a cell |
| 07/26/2012 | US20120190836 Porphyranases, and use thereof for hydrolyzing polysaccharides |
| 07/26/2012 | US20120190830 Antibody to Human Zcyto-10 Polypeptide |
| 07/26/2012 | US20120190826 Novel antibiotic comprising an antibody mimetic, its preparation methods and uses thereof |